PACB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pacific Biosciences of California Inc

Watchlist Manager

Watchlist

Price: 1.44 USD -3.36% Market Closed

Market Cap: $447.3m

	Pacific Biosciences of California Inc NASDAQ:PACB	US

Profitability Summary

Pacific Biosciences of California Inc's profitability score is 12/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

40%

Sustainable 3Y Average Gross Margin

28%

Gross Margin is Increasing

33% > 40%

Negative Operating Margin

-97%

Negative 3Y Average Operating Margin

-153%

Operating Margin is Increasing

-221% > -97%

Negative Net Margin

-80%

Negative 3Y Average Net Margin

-238%

Net Margin is Increasing

-218% > -80%

Negative Free Cash Flow Margin

-74%

Negative 3Y Average Free Cash Flow Margin

-123%

Free Cash Flow Margin is Increasing

-188% > -74%

Negative ROE

-274%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-34%

Declining ROIC

-33% > -44%

View All

Hide

Collapse

12 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.